Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
ENSC
ENSC
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ENSC News
Credo Technology Raises Revenue Guidance Significantly
6d ago
Benzinga
Ensysce Secures Brazilian Patent to Advance Safer Opioid Treatments
Jan 21 2026
Yahoo Finance
Ensysce Initiates PF614 Phase 3 Enrollment, Advancing Towards Commercialization
Dec 12 2025
Globenewswire
Ensysce Initiates PF614 Phase 3 Enrollment, Advancing Towards Commercialization
Dec 12 2025
Newsfilter
Ensysce Secures FDA Approval for PF614 Commercial Production Pathway
Nov 24 2025
Newsfilter
Ensysce Biosciences Under Review: Zacks Small-Cap Research Assigns $16.45 Price Target
Nov 17 2025
Benzinga
Diamond Equity Research Releases Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC)
Aug 15 2025
Newsfilter
Ensysce Biosciences Narrows Loss in Q2
Aug 13 2025
NASDAQ.COM
3 Penny Stocks to Watch Now, 4/24/25
Apr 24 2025
TipRanks
Why ServiceNow Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Apr 24 2025
Benzinga
Ensysce Biosciences Stock Doubles In One Trading Session - Here's Why
Apr 23 2025
Benzinga
Ensysce Biosciences announces exercise of warrants for $2.2M gross proceeds
Apr 23 2025
SeekingAlpha
Crude Oil Falls Over 3%; Philip Morris Earnings Top Views
Apr 23 2025
Benzinga
Dow Jumps Over 1,000 Points; Tesla Shares Rise After Q1 Results
Apr 23 2025
Benzinga
Ensysce Biosciences files to sell 980,000 shares of common stock for holders
Apr 16 2025
Business Insider
Ensysce Biosciences files to sell 652,439 shares of common Stock for holders
Apr 16 2025
Business Insider
Show More News
